Economic benefit of a centralized reconstitution unit of cytotoxic drugs in isolator

Journal of Oncology Pharmacy Practice

Volumn 2, Issue 3, 1996, Pages 182-185

  Favier, Mireille ^a   Fliche, Elisabeth ^a   Bressolle, Francoise ^a  

^a Hopital Gaston Doumergue   (France)

Author keywords

Centralized unit; Cytotoxic drugs; Pharmacoeconomics

Indexed keywords

EID: 0000575350     PISSN: 10781552     EISSN: 1477092X     Source Type: Journal    
DOI: 10.1177/107815529600200308     Document Type: Article

References (5)

1. Larrouturou P., Huchet J., Targoudeau MC Centralized preparation of hazardous drugs-A choice between isolator and laminar airflow. Pharm Weekly Sci. 1992; 14:88-92.
2. Friedman TS, Triboletti M., Sandusky M., Katz S. Antineoplastic admixture service in a tertiary-care hospital. Am J Hosp Pharm. 1984;41:2037-2044.
3. Favier M., Hansel S., Bressolle F. Guidelines on quality assurance for centralized preparation of cytotoxic agents in an isolator. Am J Hosp Pharm. 1993;50: 2335-2339.
4. Wernli M., Bogli F., Muhlebach S., Conen D. Centralized preparations of cytostatic agents: a method for quality control. Schweizerische Mdizinische Wochenschrift. 1994;124:1962-1965.
5. Favier M., Amirault P. Cytostatiques-Données relatives à leur préparation, leur stabilité et leurs modalités d'administration. In: Sanofi Winthorp, ed. 4th ed. Paris, Happening consultants; 1994.